Increased risk of cognitive impairment and hyperglycemia-related mortality in late middle-aged African Americans with low serum adropin levels
View ORCID ProfileAndrew A. Butler, Geetika Agarwal, Theodore K. Malmstrom, Douglas K. Miller, Andrew D. Nguyen, John E. Morley
doi: https://doi.org/10.1101/2021.12.09.21267550
Andrew A. Butler
1Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO, USA
2Henry and Amelia Nasrallah Center for Neuroscience, Saint Louis University, St. Louis, MO, USA
Geetika Agarwal
3Division of Geriatric Medicine, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MO, USA
Theodore K. Malmstrom
2Henry and Amelia Nasrallah Center for Neuroscience, Saint Louis University, St. Louis, MO, USA
4Department of Psychiatry and Behavioral Neuroscience, Saint Louis University School of Medicine, St. Louis, MO, USA
Douglas K. Miller
5Regenstrief Institute, Inc., Indianapolis, IN, USA
Andrew D. Nguyen
1Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO, USA
2Henry and Amelia Nasrallah Center for Neuroscience, Saint Louis University, St. Louis, MO, USA
3Division of Geriatric Medicine, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MO, USA
John E. Morley
3Division of Geriatric Medicine, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MO, USA
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted December 13, 2021.
Increased risk of cognitive impairment and hyperglycemia-related mortality in late middle-aged African Americans with low serum adropin levels
Andrew A. Butler, Geetika Agarwal, Theodore K. Malmstrom, Douglas K. Miller, Andrew D. Nguyen, John E. Morley
medRxiv 2021.12.09.21267550; doi: https://doi.org/10.1101/2021.12.09.21267550
Increased risk of cognitive impairment and hyperglycemia-related mortality in late middle-aged African Americans with low serum adropin levels
Andrew A. Butler, Geetika Agarwal, Theodore K. Malmstrom, Douglas K. Miller, Andrew D. Nguyen, John E. Morley
medRxiv 2021.12.09.21267550; doi: https://doi.org/10.1101/2021.12.09.21267550
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)